Effect of meloxicam and diclofenac sodium on peri-implant bone healing in rats

Journal of Periodontology

Volumn 79, Issue 2, 2008, Pages 300-306

  Pablos, Alethéia B ^a,c   Ramalho, Saturnino A ^a   König Jr , Bruno ^b   Furuse, Cristiane ^a   De Araújo, Vera C ^a   Cury, Patricia R ^a  

^a SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c São Leopoldo Mandic Dental Research Center ^*  (Brazil)

Author keywords

Bone healing; Cyclooxygenase 2; Diclofenac sodium; Meloxicam; NSAID; Osseointegration

Indexed keywords

DIAGNOSTIC AGENT; DICLOFENAC; FLUORESCENT DYE; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; DRUG EFFECT; IMPLANT; MALE; NONPARAMETRIC TEST; RAT; SPRAGUE DAWLEY RAT; TIBIA; TOOTH IMPLANTATION; WOUND HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DENTAL IMPLANTS; DICLOFENAC; FLUORESCENT DYES; IMPLANTS, EXPERIMENTAL; MALE; OSSEOINTEGRATION; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; THIAZINES; THIAZOLES; TIBIA; WOUND HEALING;

EID: 39749127697     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070301     Document Type: Article

References (65)

1. Lipsky PE. Role of cyclooxygenase-1 and -2 in health and disease. Am J Orthop 1999;28:8-12.
2. Katori M, Majima M. Cyclooxygenase-2: Its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 2000;49:367-392.
3. 2. Endocrinology 1992;130:443-448.
4. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop Relat Res 1995;313:36-46.
5. 2 in young rats increases the osteogenic capacity of bone marrow. Bone 1997;20:521-526.
6. Sato Y, Arai N, Negishi A, Ohya K. Expression of cyclooxygenase genes and involvement of endogenous prostaglandin during osteogenesis in rat tibial bone marrow cavity. J Med Dent Sci 1997;44:81-92.
7. 2 on bone mass in rat long bones and calvariae. J Endocrinol 1998;156:51-57.
8. Okada Y, Lorenzo JA, Freeman AM, et al. Prostaglandin G/H syntase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 2000; 105: 823-832.
9. 2 agonist induces bone healing. Proc Natl Acad Sci USA 2003;100: 6736-6740.
10. 2 in human mesenchymal stem cells. J Cell Physiol 2004;200:400-406.
11. O'Keefe RJ, Tiyapatanaputi P, Xie C, et al. COX-2 has a critical role during incorporation of structural bone allografts. Ann N Y Acad Sci 2006;1068:532-542.
12. Glowacki J. Angiogenesis in fracture repair. Clin Orthop Relat Res 1998;(355 Suppl.):S82-89.
13. Villars F, Bordenave L, Bareille R, Amedee J. Effect of human endothelial cells on human bone marrow stromal cell phenotype: Role of VEGF. J Cell Biochem 2000; 79:672-685.
14. Street J, Bao M, de Guzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002;99:9656-9661.
15. Gasparini G, Longo R, Sarmiento R, Morabito A. Inhibitors of cyclo-oxygenase 2: A new class of antican-cer agents? Lancet Oncol 2003;4:605-615.
16. 2 regulates the angiogenic switch. Proc Natl Acad Sci USA 2004;101:415-416.
17. Chen YJ, Wurtz T, Wang C, et al. Recruitment of mesenchymal stem cells and expression of TGFβ and VEGF in early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res 2004;22:526-534.
18. Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999;5:1418-1423.
19. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002;109:1405-1415.
20. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa 1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89:755-764.
21. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT. In vitro and in vivo synergistic interactions between the Runx2/Cbfal transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 2003; 18: 705-715.
22. Keller J, Bunger C, Andreassen TT, Bak B, Lucht U. Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop Scand 1987;58:379-383.
23. Ahrengart L, Lindgren U, Reinholt FP. Comparative study of the effects of radiation, indomethacin, prednisolone, and ethane-1-hydroxy-1,1-diphosphonate (EHDP) in the prevention of ectopic bone formation. Clin Orthop Relat Res 1988;229:265-273.
24. Trancik T, Mills W, Vinson N. The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant. Clin Orthop Relat Res 1989;249: 113-121.
25. Hogevold HE, Grogaard B, Reikeras O. Effects of short-term treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand 1992;63:607-611.
26. Altman RD, Latta LL, Keer R, Renfree K, Hornicek FJ, Banovac K. Effect of nonsteroidal antiinflammatory drugs on fracture healing: A laboratory study in rats. J Orthop Trauma 1995;9:392-400.
27. Forwood MR. Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res 1996;11:1688-1693.
28. Glassman SD, Rose SM, Dimar JR, Puno RM, Campbell MJ, Johnson JR. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 1998;23:834-838.
29. Giannoudis PV, MacDonald DA, Matthews SJ, Smith RM, Furlong AJ, De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br 2000; 82:655-658.
30. Simon AM, Manigrasso MB, O'Connor JP. Cyclooxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002;17:963-976.
31. Goodman S, Ma T, Trindade M, Ikenoue T, et al. COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 2002;20:1164-1169.
32. Gerstenfeld LC, Thiede M, Seibert K, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003;21:670-675.
33. Endo K, Sairyo K, Komatsubara S, et al. Cyclooxygenase-2 inhibitor delay the fracture healing in rats. Acta Orthop 2005;76:470-474.
34. Leonelli SM, Goldberg BA, Safanda J, Bagwe MR, Sethuratnam S, King SJ. Effects of a cyclooxygenase-2 inhibitor (rofecoxib) on bone healing. Am J Orthop 2006;35:79-84.
35. Keller JC, Trancik TM, Young FA, St Mary E. Effects of indomethacin on bone ingrowth. J Orthop Res 1989;7: 28-34.
36. Jacobsson SA, Djerf K, Ivarsson I, Wahlstrom O. Effect of diclofenac on fixation of hydroxyapatite-coated implants. An experimental study. J Bone Joint Surg Br 1994;76:831-833.
37. Cook SD, Barrack RL, Dalton JE, Thomas KA, Brown TD. Effects of indomethacin on biologic fixation of porous-coated titanium implants. J Arthroplasty 1995; 10:351-358.
38. Reddy MS, Jeffcoat MK, Richardson RC. Assessment of adjunctive flurbiprofen therapy in root-form implant healing with digital subtraction radiography. J Oral Implantol 1990;16:272-276.
39. Sennerby L, Kalebo P, Thomsen P, Albrektsson T. Influence of indomethacin on the regeneration of cortical bone within titanium implants in rabbits. Biomaterials 1993;14:156-158.
40. Weber HP, Fiorellini JP, Paquette DW, Howell TH, Williams RC. Inhibition of peri-implant bone loss with the nonsteroidal anti-inflammatory drug flurbiprofen in beagle dogs. A preliminary study. Clin Oral Implants Res 1994;5:148-153.
41. Goodman S, Ma T, Mitsunaga L, Miyanishi K, Genovese MC, Smith RL. Temporal effects of a COX-2 selective NSAID on bone ingrowth. J Biomed Mater Res Part A 2005;72:279-287.
42. Brideau C, Kargman S, Liu S, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res 1996; 45:68-74.
43. Patrignani P, Panara MR, Sciulli MG, Santini G, Renda G, Patrono C. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J Physiol Pharmacol 1997;48:623-631.
44. Engelhardt G. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 1996;35:4-12.
45. Ogino K, Hatanaka K, Kawamura M, Katori M, Harada Y. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Pharmacology 1997;55: 44-53.
46. Van Hecken A, Schwartz Jl, Depre M, et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol 2000; 40:1109-1120.
47. Pairet M, vanRyn J, Schierok H, Mauz A, Trummlitz G, Engelhardt G. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomer. Inflamm Res 1998;47:270-276.
48. Busch U, Schmid J, Heinzel G, et al. Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab Dispos 1998;26:576-584.
49. Rahn BA. Polychrome sequential labeling (in German). [Thesis]. Freiburg, Germany: Albert-Ludwigs University; 1976. 146p.
50. Donath K, Breuner GA. A method for the study of undecalcified bones and teeth with attached soft tissue. J Oral Pathol 1982;11:318-326.
51. Iyama S, Takeshita F, Ayukawa Y, et al. A study of regional distribution of bone formed around hydroxyapatite implants in the tibiae of streptozotocin-induced diabetic rats using multiple fluorescent labeling and confocal laser scanning microscopy. J Periodontol 1997;68:1169-1175.
52. Shani J, Amir D, Soskolne WA, et al. Correlation between uptake of technetium, calcium, phosphate, and mineralization in rat tibial bone repair. J Nucl Med 1990;31:2011-2014.
53. Raisz LG, Pilbeam CC, Fall PM. Prostaglandins: Mechanisms of action and regulation of production in bone. Osteoporos Int 1993;3:136-140.
54. 2 after trauma attenuates proinflammatory cytokines and improves survival. Shock 2000;14:374-379.
55. Ribeiro FV, Cesar-Neto JB, Nocciti FH Jr., et al. Selective cyclooxygenase-2 inhibitor may impair bone healing around titanium implants in rats. J Periodontol 2006;77:1731-1735.
56. Takeshita F, Iyama S, Ayukawa Y, et al. The effects of diabetes on the interface between hydroxyapatite implants and bone in rat tibia. J Periodontol 1997;68:180-185.
57. Takeshita F, Murai K, Iyama S, et al. Uncontrolled diabetes hinders bone formation around titanium implants in rat tibiae. A light and fluorescent microscopy, and image processing study. J Periodontol 1998;69: 314-320.
58. Nevins ML, Karimbux NY, Weber HP, et al. Wound healing around endosseous implants in experimental diabetes. Int J Oral Maxillofac Implants 1998;13:620-629.
59. Fujii N, Kusakari H, Meda T. A histological study on tissue responses to titanium implantation in rat maxilla: The process of epithelial regeneration and bone reaction. J Periodontol 1998;69:485-495.
60. Torres-Lopez JE, Lopez-Munhoz FJ, Castaneda-Hernandez G, Flores-Murrieta FJ, Granados-Soto V. Pharmacokinetic-pharmacodynamic modeling of antinociceptive effect of diclofenac in the rat. J Pharmacol Exp Ther 1997;282:685-690.
61. Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol 1979;16:405-410.
62. Kurowski M. Pharmacokinetics and biological availability of diclofenac preparations following intramuscular injection of 75 mg and oral administration of 150 mg of active drug (in German). Z Rheumatol 1988;47:37-42.
63. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995;66:329-338.
64. Bauer DC, Orwoll ES, Fox KM, et al. Aspirin and NSAID use in older women: Effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996;11: 29-35.
65. Lane NE, Bauer DC, Nevitt MC, Pressman AR, Cummings SR. Aspirin and nonsteroidal anti-inflammatory drug use in elderly women: Effects on a marker of bone resorption. J Rheumatol 1997;24:1132-1136.